Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
Robert Cabrera & Colleagues Developed the ELISA-Based Folate Receptor Autoantibody Assay
Robert Cabrera/LinkedIn
Sep 24, 2025, 15:57

Robert Cabrera & Colleagues Developed the ELISA-Based Folate Receptor Autoantibody Assay

Robert Cabrera, Associate Professor at Baylor College of Medicine, shared on LinkedIn:

“I (we) developed the ELISA-based folate receptor autoantibody assay in 2008 based on Rothenberg’s 2004 study on neurodevelopmental risks (NTDs).

Today, 17-21 years later, folate receptor autoantibodies were mentioned in a US Presidential press conference on autism, which included Tylenol (acetaminophen) risks, and proposed treatment with reduced folate (folinic acid, leucovorin).”

Title: Autoantibodies to folate receptor during pregnancy and neural tube defect risk

Authors: Robert M Cabrera, Gary M Shaw, Johnathan L Ballard, Suzan L Carmichael, Wei Yang, Edward J Lammer, Richard H Finnell

Robert Cabrera & Colleagues Developed the ELISA-Based Folate Receptor Autoantibody Assay

Read more here.

Stay updated with Hemostasis Today.

acetaminophen Autoantibody Baylor College of Medicine Edward J Lammer ELISA folinic acid Gary M Shaw Health Hematology Hemostasis Hemostasis Today Johnathan L Ballard leucovorin Medicine neural tube defect Neurodevelopmental Risks Pregnancy Richard H Finnell Robert M Cabrera Suzan L Carmichael thrombosis Tylenol Wei Yang
NewsFeed